Moderna stock surges as melanoma vaccine trial shows "landmark moment"

Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.

• Aug 19

FDA approves Moderna's mRNA flu vaccine after initial pushback

The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the drugmaker announced.

• Aug 6

Trump administration yanks Moderna's bird flu vaccine research funding

The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic influenza viruses, including the H5N1 bird flu.

• May 29, 2025

Moderna announces test results for skin cancer vaccine

A vaccine and cancer drug dramatically improved survival rates for those with severe melanomas, results after three years showed.

• Dec 14, 2023

Federal officials prepare for end of free COVID vaccines as funds run dry

The federal budget for buying and distributing COVID-19 vaccines will run out "as early as January."

• Sep 2, 2022

Updated COVID boosters targeting Omicron start rolling out

Federal health officials say thousands of updated booster shots are already being shipped around the country.

• Sep 1, 2022

Here's when COVID vaccines for kids under 5 should finally roll out

The White House says doses will be available everywhere from pediatricians' offices to children's museums, if health authorities sign off on the shots later this month.

• Jun 9, 2022